Best of 2020

by Lindsay Valiante

Top five Essential Insights articles in 2020 that provided actionable advice on the critical and fast-changing healthcare industry. These can’t-miss stories highlighted an array of topics from the COVID-19 pandemic impact to advice and success stories for pharmacy owners.

Closing the gender gap in cancer research

by Laura Mueller

Experts look at why a gender gap exists in cancer research and what's being done to fix it.

The best of 2019

by Stephanie Pavol

This Essential Insights articles with the biggest impact over the last year.

Four trends impacting pharmacists

by Tom Halterman and Brent Stutz

Experts provide a look at four key trends impacting the role of pharmacists and the expanding need for medication therapy management.

Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.
Home is where the healthcare is.

Home is where...the healthcare is?

by Stephanie Pavol and Kristen Fischer

An industry survey found that 44 percent of healthcare organizations want to invest more in home healthcare. Here’s a deeper look at how hospital care is going to and following the patient—and what this means for healthcare providers.

Physician leaning against the wall looking at a tablet.

AI and gamification in cancer care

by Joe DePinto

New research shows how more than 180 oncologists nationwide feel about these two emerging technologies.

Pill capsules.

The impact of pharmacogenomics on patients and providers

by Scott Lust

Your genes may impact your body’s response to medications. Here’s what that means for medication therapy.

Sales rep talking to a doctor.

Three key insights from the AHIP Institute & Expo

by Stephanie Pavol

Didn’t make it to the America's Health Insurance Plans' Institute & Expo? We break down what you need to know from the event.

gene therapy.

The three most important challenges to overcome for cell and gene therapy success

by Chris Hayhurst

A closer look at the new challenges biopharmaceutical companies may encounter as they navigate the evolving cell and gene therapy market—and some promising solutions.

of 53 remaining articles